EUDA
REAL ESTATEEUDA Health Holdings Limited
AI Insight
What's Moving EUDA Today?
No stock-specific AI insight has been generated for EUDA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.26$86.00
$14.30
Fundamentals
Market Cap$43M
P/E Ratio—
EPS$-1.48
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin-40.7%
Debt / Equity—
Trading
Volume5K
Avg Volume (10D)—
Shares Outstanding3.0M
EUDA News
24 articles- Tan Meng Dong holds 15.3% of EUDA (NASDAQ: EUDA) in amended Schedule 13GStock Titan·Jun 9, 2026
- Stem cell skincare: EUDA targets $8B face mask market with RegenixéStock Titan·Jun 1, 2026
- EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome MaskYahoo Finance·Jun 1, 2026
- EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value DeficiencyYahoo Finance·Jun 1, 2026
- EUDA Health restores Nasdaq listing compliance after value shortfallStock Titan·Jun 1, 2026
- EUDA - Euda Health Holdings Limited Stock Price and QuoteFinviz·May 27, 2026
- EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy DevelopmentGlobeNewswire Inc.·Apr 28, 2026
- EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed SecuritiesGlobeNewswire Inc.·Apr 27, 2026
- EUDA Announces Reverse Stock Split of its Ordinary SharesYahoo Finance·Mar 19, 2026
- EUDA Health price target lowered to $2.75 from $6 at GreenridgeYahoo Finance·Mar 10, 2026
- EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville WarrantYahoo Finance·Mar 4, 2026
- EUDA Health Announces Second Amendment to Streeterville Warrant AgreementYahoo Finance·Jan 15, 2026
- EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy PlatformYahoo Finance·Jan 13, 2026
- EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant AgreementYahoo Finance·Jan 7, 2026
- EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien HospitalYahoo Finance·Dec 30, 2025
- EUDA Health to Launch EUDA Helixé 2.0 in January 2026Yahoo Finance·Dec 29, 2025
- Top Midday GainersYahoo Finance·Dec 23, 2025
- EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in ShenzhenYahoo Finance·Dec 23, 2025
- Top Midday DeclinersYahoo Finance·Dec 22, 2025
- EUDA Health Holdings Limited Announces Execution of Securities Purchase AgreementYahoo Finance·Dec 5, 2025
- EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock IndiaYahoo Finance·Oct 23, 2025
- EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across AsiaYahoo Finance·Oct 20, 2025
- EUDA Signs Letter of Intent to Potentially Acquire GO POSBYahoo Finance·Sep 10, 2025
- EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy PortfolioYahoo Finance·Sep 4, 2025
All 24 articles loaded
Price Data
Open$14.95
Previous Close$14.30
Day High$15.08
Day Low$14.30
52 Week High$86.00
52 Week Low$5.26
52-Week Range
$5.26$86.00
$14.30
Fundamentals
Market Cap$43M
P/E Ratio—
EPS$-1.48
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin-40.7%
Debt / Equity—
Trading
Volume5K
Avg Volume (10D)—
Shares Outstanding3.0M
About EUDA Health Holdings Limited
EUDA Health Holdings Limited is a forward-looking biopharmaceutical company focused on innovating treatments for rare diseases and addressing unmet medical needs. Leveraging advanced technologies, the firm is developing a robust clinical pipeline with a particular emphasis on supportive care and immune modulation. EUDA's strong commitment to research and development positions it favorably in the healthcare landscape, aiming to enhance patient outcomes and expand access to crucial therapies.
REAL ESTATEREAL ESTATE SERVICES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICREAL ESTATE SERVICES
CIK—
Composite FIGI—
Share Class FIGI—